secwatch.observer — SEC 8-K summary
======================================

Issuer:     Savara Inc (SVRA)
CIK:        0001160308
Form:       8-K
Filed at:   2022-01-10T23:59:59+00:00
Accession:  0001193125-22-005111
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Savara updates corporate presentation; no specific financial or clinical data disclosed in filing
--------------------------------------------------------------------------------

- Corporate presentation furnished as Exhibit 99.1, available on Savara's IR website.
- Presentation title indicates continued focus on rare respiratory diseases.
- No material changes or new quantitative information provided in the 8-K or exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1160308/000119312522005111/0001193125-22-005111-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1160308/000119312522005111/d264857d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-005111

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer